Ifs Recommendations for Covid 19 Vaccination Before Art

Total Page:16

File Type:pdf, Size:1020Kb

Ifs Recommendations for Covid 19 Vaccination Before Art 16 – 17 JULY 2020 PRAGATI MAIDAN - DELHI INDIAN FERTILITY SOCIETY IFS RECOMMENDATIONS FOR COVID 19 VACCINATION BEFORE ART IFS SECRETARIAT +91 11 40018184 +91 9899308083 indianferlitysociety [email protected] www.indianferlitysociety.org indianferlitysociety 302, 3rd Floor, Kailash Building, ifsdelhi 26, Kasturba Gandhi Marg, C.P. New Delhi - 110001 Cosmo Tech is the Most Important Trade show for the Suppliers to EXPAND Strengthen Increase Multiply Profits New Markets Pan New Market Customer Base India & World Customer Soaring Boost Network Brand Sales Brand Recall Value with the Industry Visibility ORGANIZED BY CALL EMAIL +91 9971811937 [email protected] +91 9999302797 [email protected] +91 9811141938 [email protected] W W W .C O SMO TEC HEXPO IND IA .C O M Dr. Sudha Prasad Dr. Neena Malhotra President Secretary General Indian Fertility Society Indian Fertility Society Director, Matritava Advanced IVF & Professor, ART Centre, Department of Training Cenre, Vasant Vihar, New Delhi Obstetrics and Gynaecology, AIIMS, New Delhi Dr. Sonia Malik Dr. Kuldeep Jain Past President Indian Fertility Society, Past President Indian Fertility Society, Director & Nova Southend Fertility & Director, KJIVF New Delhi IVF Delhi NCR Dr. KU Kunjumoideen Dr. A K Pandey Joint Secretary Indian Fertility Society, Dean Academics &. Co Ordinator Director ARMC IVF Calicut. Molecular Lab. ESI Medical college Faridabad Dr. Charu Jandial Dr. Sumita Aggarwal Member IFS, Consultant, Member IFS, Fellow, Nova Southend Fertility & IVF Delhi NCR Nova Southend Fertility & IVF Delhi NCR Introduction The coronavirus pandemic has wreaked havoc on life In these trying mes, as sociees are gradually trying to and healthcare globally. According to WHO database as return to a state of normalcy, it is also important to on 7th June 2021, there have been 173 million consider sexual and reproducve health of people. confirmed covid19 cases worldwide and 3.7 million Couples seeking concepon are parcularly distressed deaths. The World Health Organizaon declared the and need clear guidelines to help them make decisions outbreak a Public Health Emergency of Internaonal about their treatment. Concern on 30 January 2020, and a pandemic on 11 March 2020. SARS CoV 2 is a posive-sense single- This document of the IFS has been prepared aer taking stranded RNA virus that is contagious in humans. As inputs from all the chapter secretaries of the IFS and described by the US Naonal Instutes of Health, it is the hence includes insights and common queries addressed successor to SARS-CoV-1, the virus that caused the by the healthcare providers across the country. It 2002–2004 SARS outbreak intends to provide both the providers and the paents an overview of covid vaccinaon in paents desiring India is just recovering from the deadly second wave of ferlity in order to help them make an informed choice the pandemic with more than 28 million confirmed regarding the vaccinaon. cases and 3.49 lakh deaths. The virus Covid 19 disease is caused by the virus, SARS CoV2( entry using ACE2. Aer a SARS CoV 2 virion aaches to a Severe acute respiratory syndrome coronavirus 2) which target cell, the cell's TMPRSS2 cuts open the spike is a beta coronavirus. Coronaviruses infect humans, protein of the virus, exposing a fusion pepde in the S2 other mammals, and avian species, including livestock subunit, and the host receptor ACE2. Aer fusion, an and companion animals. Human coronaviruses are endosome forms around the virion, separang it from capable of causing illnesses ranging from the common the rest of the host cell. The virion escapes when the pH cold to more severe diseases such as Middle East of the endosome drops or when cathepsin, a host respiratory syndrome (MERS, fatality rate ~34%). SARS- cysteine protease, cleaves it.The virion then releases CoV-2 is the seventh known coronavirus to infect RNA into the cell and forces the cell to produce and people, aer 229E, NL63, OC43, HKU1, MERS-CoV, and disseminate copies of the virus, which infect more cells. the original SARS-CoV. SARS CoV 2 produces at least three virulence factors that It bears 80% homology to SARS Cov and 50% to MERS(1) promote shedding of new virions from host cells and .Each SARS-CoV-2 virion is 50–200 nanometres in inhibit immune response. diameter. An understanding of the structure of the virus has It is an enveloped posive-sense single stranded RNA helped in developing prevenve and treatment virus with four main structural proteins i.e. Spike (S) strategies against it. protein, Membrane (M) protein, Nucleocapsid (N) protein and envelope (E) protein(2). In SARS-CoV-2, the spike protein, which has been imaged at the atomic level using cryogenic electron microscopy, is the protein responsible for allowing the virus to aach to and fuse with the membrane of a host cell; specifically, its S1 subunit catalyzes aachment, the S2 subunit fusion. It binds to angiotensin receptor conversion enzyme 2 (ACE2) on host cells for viral entry and with the help of Transmembrane serine proteases 2 (TMPRSS2) is incorporated in host cell wall(3).Inial spike protein priming by transmembrane protease, serine 2 (TMPRSS2) is essenal for entry of SARS CoV 2.] The host protein neuropilin 1 (NRP1) may aid the virus in host cell The Need of Vaccination Impact on Reproduction: Covid 19 may influence both male and female steroidogenesis, germ cells and reproducve health.(4) The reproducve system in both sexes has abundant ACE2 receptors and are suscepble to SARS CoV 2 infecon. Studies have suggested that downregulaon of ACE 2 may cause alteraon in follicular development and oocyte maturaon affecng their quality and subsequently affecng embryo development. Also increased oxidave stress may have detrimental pro inflammatory effect. Endometrial recepvity may also be altered leading to unfavourable outcomes.(5) Hajizadeh Malekiand Tarbian conducted a prospecve, longitudinal cohort study of 84men with confirmed COVID 19, and 105 men without the disease in Iran. The researchers analyzed changes in angiotensin-converng enzyme 2 (ACE2) acvity, markers of inflammaon and oxidave stress, apoptoc variables and semen quality, all of which were evaluated at 10-day intervals for up to 60 days. They also had higher levels of reacve oxygen species and lower superoxide dismutase acvity compared with healthy controls. The markers of inflammaon and oxidave stress in sperm cells of men with COVID-19 were increased by more than 100% compared with controls, according to the researchers. Sperm concentraon was reduced by 516%, mobility by 209% and sperm cell shape was altered by 400%.Although these effects were reported to improve over me — represenng “a transient state of male subferlity like those with oligoasthenoteratozoospermia” — the researchers wrote they remained “significantly and abnormally higher in the COVID-19 paents, and the magnitude of these changes were also related to disease severity.” Basigin (BSG) is also one of the most crucial receptors for COVID-19 that mediates its entry to host cells. BSG is expressed not only in the uterus but also in the stroma and granulosa cells of the ovary. BSG may play a role during follicle development, corpus luteum formaon and embryo implantaon. In men viral orchis may develop and impair semen parameters albeit transiently. The long term effects sll need to be evaluated.(6) Covid 19 infecon in pregnant women is more severe than their nonpregnant counterparts with increased morbidity and mortality and adverse perinatal outcome in the form of preterm birth, growth restricon, sll birth and increased caesarean delivery(7)(8). Also vercal transmission though not proven is sll a possibility.(9) The psychological effects of stress due to fear of the disease, social restricons and financial implicaons may also disturb the HPO axis. Drugs used in the treatment of Covid 19 infecon and sanizaon agents in the environment may also result in changes at the molecular level and have a bearing on the ferlity potenal of a couple. (4) RECOMMENDATION Even though the evidence is scant, it is important to (a) scarcity or non-availability of vaccine in some prevent this infecon as well as augment immunity states, against this infecon prior to commencing ferlity (b) medical condions like ferlity preservaon for treatment. cancer, advanced age, poor ovarian reserve etc. IFS therefore recommends vaccinaon before In these circumstances, the paent may be advised to iniang ferlity treatment. However, certain iniate treatment but the final decision may be le to circumstances may warrant iniaon of treatment the paent aer explaining all pros and cons and an before taking the vaccine, for instance, informed consent taken before starng treatment. The vaccine can be taken as and when it becomes available. Prevention of infection Though risk migaon measures like wearing a mask, maintaining hand hygiene and social distancing remain the best prevenve strategy, availability of vaccines have provided a new hope of curtailing the virus and averng further waves of Covid 19. Generally, any vaccine which is available can be taken by those seeking pregnancy with the excepon of live aenuated one to avoid harm in case of accidental pregnancy. For paents who have already been infected with COVID, IFS advises to take the vaccinaon in order to enhance their immunity and dampen the effect of a re infecon if it occurs. The various covid vaccines are being developed using different plaorms like nucleic acid based, viral vector based, protein
Recommended publications
  • 0 January to July 2021
    0 www.journalsofindia.com January to July 2021 SCIENCE & TECH ............................................................................................................................................................... 6 1. REUSABLE LAUNCH VEHICLE TECHNOLOGY DEMONSTRATION PROGRAMME(RLV-TD) ................................................. 6 2. GAGANYAAN MISSION ..................................................................................................................................................... 6 3. MARS ORBITER MISSION (MOM) ..................................................................................................................................... 6 4. CHANDRAYAAN MISSION................................................................................................................................................. 7 5. SOLAR MISSION ............................................................................................................................................................... 8 6. ARTEMIS ACCORD ............................................................................................................................................................ 9 7. NATIONAL MISSION ON INTERDISCIPLINARY CYBER-PHYSICAL SYSTEM (NMICPS) ....................................................... 10 8. SMART ANTI-AIRFIELD WEAPON (SAAW) ...................................................................................................................... 10 9. AQUAPONICS ................................................................................................................................................................
    [Show full text]
  • COVID-19 Summary of Guidelines
    [3] Table of Contents 1. Containment Plan for Large Outbreaks: Novel Corona Virus Disease 2019 (COVID-19 ............................... 7 2. Social Stigma Associated with COVID-19....................................................................................................... 7 3. Guidelines for Dialysis with reference to COVID 19 Infection ....................................................................... 7 4. Guidance document on appropriate management of suspect/ confirmed cases of COVID 19......................... 7 5. COVID - 19 testing laboratories approved and supported by ICMR as on 07/04/2020 ................................... 8 6. Railways meet half initial target in a quick time ............................................................................................... 8 7. DST supported healthcare startup developing rapid test for detection of COVID-19 .................................... 8 8. Check urgently the virus of misinformation on COVID-19: Vice President .................................................... 8 9. Guidelines for Quarantine facilities................................................................................................................. 9 10. Advisory on use of Homemade Protective Cover for Face & Mouth .............................................................. 9 11. Advisory to start rapid antibody-based blood test for COVID-19 .................................................................. 9 12. MHA writes to States/UTs to ensure smooth Disbursal of Money to beneficiaries
    [Show full text]
  • Review of COVID-19 Vaccine Subtypes, Efficacy and Geographical Distributions Andre Ian Francis ‍ ‍ ,1 Saudah Ghany,1 Tia Gilkes,1 Srikanth Umakanthan2
    Review Postgrad Med J: first published as 10.1136/postgradmedj-2021-140654 on 6 August 2021. Downloaded from Review of COVID-19 vaccine subtypes, efficacy and geographical distributions Andre Ian Francis ,1 Saudah Ghany,1 Tia Gilkes,1 Srikanth Umakanthan2 1Department of Clinical Medical ABSTRACT 2021, the Ad26.COV2.S, developed by Janssen Sciences, The Faculty of Medical As of 1 May 2021, there have been 152 661 445 (Johnson & Johnson) and Moderna on 30 April.4 Sciences, The University of the COVAX, coordinated by WHO, Gavi: The West Indies, St. Augustine, Covid-19 cases with 3 202 256 deaths globally. Trinidad and Tobago This pandemic led to the race to discover a vaccine Vaccine Alliance, the Coalition for Epidemic 2Pathology unit, Department to achieve herd immunity and curtail the damaging Preparedness Innovations (CEPI), acts as a of Paraclinical Sciences, The effects of Covid-19. This study aims to discuss the most programme that supports the development of University Of The West Indies, St. COVID-19 vaccine candidates and negotiates their Augustine, Trinidad and Tobago recent WHO-approved Covid-19 vaccine subtypes, their status and geographical scheduled updates as of 4 pricing to ensure low- and- middle- income countries have a fair shot at receiving vaccines.5 Correspondence to May 2021. The keywords “Covid-19, Vaccines, Pfizer, Mr. Andre Ian Francis, The BNT162b2, AstraZeneca, AZD1222, Moderna, mRNA- This article aims at discussing the most recent University of the West Indies, St. 1273, Janssen, Ad26.COV2.S” were typed into PubMed. WHO- approved COVID-19 vaccine subtypes, their Augustine, Trinidad and Tobago; Thirty Two relevant PubMed articles were included in status and geographical scheduled updates as of 4 andre.
    [Show full text]
  • Bcpct]Ttsbc^Prc U^A Dq[XRV^^S
    6 < %()(=#%% 53%7==,>3='$()6(=#%% (#-'>3='$()6(=#%% $'()"*$+&,- %( !"# $$%& 2(*3-% (566)(37)% 3 0 4 $5 3 $1 2 0 .8 9 8 ++0 0 .:; . !" . / 01 $ %'( $) '# *' it for the last eight to nine notable achievements to its months, “where is the UN in name in the 75 years of its aking a strong case for a this joint fight. Where is the experience, including the pre- Msignificant role for India effective response.” vention of a third world war, in the United Nations, Prime Focussing on a more “we can’t deny terrorist attacks 0 Minister Narendra Modi on prominent role for India in the shook the world”. Saturday stressed the need for UN and fight against corona, “We have successfully ne of the oldest partners changes in the international the Prime Minister avoided avoided a third world war but Oof the BJP — the body and questioned its posi- making any reference to ongo- we cannot deny many wars Shiromani Akali Dal — which tion in fighting the coron- ing tension at the Line of happened, many civil wars has been with it through thick avirus pandemic. Actual Control (LAC) and happened. Terrorist attack and thin for decades, finally He also assured the global frosty ties with Pakistan in his shook the world. Blood was quit the National Democratic Q community that India will pro- 20-minute speech. He also did spilled. Those were killed were Alliance (NDA) on Saturday, vide corona vaccine to the not respond to Pakistan Prime like you and me. Children left signaling a complete political world as it is the world’s biggest Minister Imran Khan’s remarks the world prematurely,” he said.
    [Show full text]
  • HYDERABAD, SATURDAY, JUNE 5, 2021; PAGES 12 `3 RNI No
    Follow us on: @TheDailyPioneer facebook.com/dailypioneer HYDERABAD, SATURDAY, JUNE 5, 2021; PAGES 12 `3 RNI No. TELENG/2018/76469 Established 1864 Published From HYDERABAD DELHI LUCKNOW BHOPAL RAIPUR CHANDIGARH BHUBANESWAR RANCHI DEHRADUN VIJAYAWADA *LATE CITY VOL. 3 ISSUE 226 *Air Surcharge Extra if Applicable www.dailypioneer.com Managed second wave, P RBI keeps interest rates unchanged P ‘Keen on signing scripts P ‘very well’; ready for 3rd: NITIA that are fun 5 announces measures to aid economy 8 entertaining, challenging’ 11 In brief IMPORT VACCINE, SAVE Petrol crosses Etela quits Assembly, TRS Pfizer vaccine for Rs 100/litre Ex-minister confirms he would be joining BJP; 12-15 age group PEOPLE, KTR TELLS CENTRE mark in TS, AP launches no-holds-barred attack on KCR gets nod in the UK ML MELLY MAITREYI ritain's medicines regulator said PNS n HYDERABAD PNS n NEW DELHI n HYDERABAD Friday the Pfizer/BioNTech B vaccine is safe for adolescents Minister KT Rama Rao on Friday After Rajasthan, Madhya Pradesh Former minister Etela Rajender let aged 12 to 15 after a "rigorous review", targeted the Centre again for its and Maharashtra, petrol price the suspense over his political following similar assessments in the “bungling” on Covid-19 vaccina- has crossed the Rs 100-per-litre future hang for some time even as EU and US."We have carefully tion and demanded that it imme- mark in almost all districts of AP he resigned from the Membership reviewed clinical trial data in children diately import vaccines from coun- and parts of Telangana after fuel of the State Legislative Assembly aged 12 to 15 years and have tries that are sitting on a huge prices were again hiked on Friday.
    [Show full text]
  • COVID-19 and Immigration Tracker
    Mobility: Immigration Tracker Impact of COVID-19 on global immigration 10 February 2021 Important notes • This document provides a snapshot of the policy changes that have been announced in jurisdictions around the world in response to the COVID-19 crisis. It is designed to support conversations about policies that have been proposed or implemented in key jurisdictions • Policy changes across the globe are being proposed and implemented on a daily basis. This document is updated on an ongoing basis but not all entries will be up-to-date as the process moves forward. In addition, not all jurisdictions are reflected in this document • Find the most current version of this tracker on ey.com • Please consult with your EY engagement team to check for new updates and new developments EY teams have developed additional trackers to help you follow changes: ► Force Majeure ► Global Mobility ► Global Tax Policy ► Global Trade Considerations ► Labor and Employment Law ► Tax Controversy ► US State and Local Taxes EY professionals are updating the trackers regularly as the situation continues to develop. Page 2 Impact of COVID-19 on Global Immigration Overview/key issues • With the crisis evolving at different stages globally, government authorities continue to implement immigration-related measures to limit the spread of the COVID-19 pandemic and protect the health and safety of individuals in and outside of their jurisdictions. • Measures to stem the spread of COVID-19 include the following: • Entry restrictions and heightened admission criteria
    [Show full text]
  • Different Types of COVID-19 Vaccines
    Pfizer-BioNTech Help stop the pandemic Type of vaccine: Messenger RNA, or mRNA, a genetic Different Types material that tells your body how to make proteins that by getting vaccinated triggers an immune response inside our bodies of COVID-19 Effectiveness: 95% based on clinical trials Even if you are undocumented Common side effects: Pain and/or swelling in the arm and/or don’t have insurance, you and tiredness, headache, muscle pain, chills, fever, or can get the vaccine—for free. Vaccines: nausea in the body that may last two days Recommended Ages: 16 and older (currently testing the vaccine in kids ages 12-15) Understanding How Dosage: Two shots, 21 days apart They Work Visit VaccinateALL58.com Moderna for the newest information about when and where the vaccine Type of vaccine: Messenger RNA, or mRNA, a genetic will be available to you. material that tells your body how to make proteins that triggers an immune response inside our bodies Sign up at myturn.ca.gov or Effectiveness: 94.1% based on clinical trials call 1-833-422-4255 to find out Common side effects: Pain and/or swelling in the arm if it’s your turn to get vaccinated and and tiredness, headache, muscle pain, chills, fever, or schedule vaccination appointments. nausea in the body that may last two days Recommended Ages: 18 years and older (currently testing the vaccine in kids ages 12-17) Dosage: Two shots, 28 days apart Johnson & Johnson Follow us on social media for more COVID-19 tips and information. Type of vaccine: A viral vector, it uses a harmless version of a different
    [Show full text]
  • Dr Omar Khorshid, Doorstop, Fremantle, Tuesday, 4 May 2021
    Australian Medical Association Limited ABN 37 008 426 793 42 Macquarie Street, Barton ACT 2600: PO Box 6090, Kingston ACT 2604 Telephone: (02) 6270 5400 Facsimile (02) 6270 5499 Website : http://www.ama.com.au/ Transcript: AMA President, Dr Omar Khorshid, Doorstop, Fremantle, Tuesday, 4 May 2021 Subject: Australians in India, hospital supplies, COVID restrictions on birthing suites, aged care OMAR KHORSHID: Today, I wrote to the Prime Minister Scott Morrison and Federal Health Minister Greg Hunt, on behalf of the AMA, asking them to immediately withdraw the threats to Australians who are stranded in India, to jail them, imprison them, or fine them heavily for simply wanting to return home and to escape the devastation that is occurring at the moment in India. To be clear, the AMA is supportive of the pause on flights so that our hotel quarantine system can be readied for the increased risk that we are clearly seeing now of Australians returning with the virus, making absolutely sure that Australia is safe in the event that we have increased numbers coming through from India. But the announcement from the Government has caused a lot of distress in our community. There's been outrage from a very wide range of groups, including many doctors, AMA members, and in particular members of our Indian medical community who have been distressed beyond words with this announcement, on top of the distress that they're already experiencing with friends and family being exposed to the terrible risks that are occurring in India. We believe that there is a clear way forward here.
    [Show full text]
  • Polity (PRE-Cure)
    Polity (PRE-Cure) April 2020 - March 2021 Visit our website www.sleepyclasses.com or our YouTube channel for entire GS Course FREE of cost Also Available: Prelims Crash Course || Prelims Test Series T.me/SleepyClasses Table of Contents Links to the videos on YouTube .................1 32. GARUD Portal ...................................18 1. Punjab Village and Small Towns Act 3 33. Samudra Setu ....................................18 2. Sections 269 & 270 IPC ................3 34. Online Summit of NAM Contact Group 3. Pradhan Mantri Garib Kalyan Yojana 18 3 35. “The Saras Collection” on the 4. New Domicile Rules for J&K .........5 Government e-Marketplace Portal 19 5. Medical Devices notified as Drugs 5 36. Dilution of Labour Laws .................20 6. NPPA ...................................................6 37. Data sharing under Arogya Setu Act 20 7. Lifeline UDAN ...................................6 38. Shetkar Committee recommendations 8. Stranded in India Portal .................6 accepted ...............................................21 9. PM CARES Fund ...............................6 39. GOAL Programme ............................22 10. PMNRF ...............................................7 40. Project Arth Ganga ..........................23 11. National Security Act .....................7 41. One Nation, One Channel- Education 12. MPLAD Scheme ...............................8 Initiatives .............................................23 13. Arogya Setu .......................................9 42. National Test Abhyaas App ...........24
    [Show full text]
  • Adenoviral Vector COVID-19 Vaccines: Process and Cost Analysis
    processes Article Adenoviral Vector COVID-19 Vaccines: Process and Cost Analysis Rafael G. Ferreira 1,* , Neal F. Gordon 2, Rick Stock 2 and Demetri Petrides 3 1 Intelligen Brasil, Sao Paulo 01227-200, Brazil 2 BDO USA, LLP, Boston, MA 02110, USA; [email protected] (N.F.G.); [email protected] (R.S.) 3 Intelligen, Inc., Scotch Plains, NJ 07076, USA; [email protected] * Correspondence: [email protected] Abstract: The COVID-19 pandemic has motivated the rapid development of numerous vaccines that have proven effective against SARS-CoV-2. Several of these successful vaccines are based on the adenoviral vector platform. The mass manufacturing of these vaccines poses great challenges, especially in the context of a pandemic where extremely large quantities must be produced quickly at an affordable cost. In this work, two baseline processes for the production of a COVID-19 adenoviral vector vaccine, B1 and P1, were designed, simulated and economically evaluated with the aid of the software SuperPro Designer. B1 used a batch cell culture viral production step, with a viral titer of 5 × 1010 viral particles (VP)/mL in both stainless-steel and disposable equipment. P1 used a perfusion cell culture viral production step, with a viral titer of 1 × 1012 VP/mL in exclusively disposable equipment. Both processes were sized to produce 400 M/yr vaccine doses. P1 led to a smaller cost per dose than B1 ($0.15 vs. $0.23) and required a much smaller capital investment ($126 M vs. $299 M). The media and facility-dependent expenses were found to be the main contributors to the operating cost.
    [Show full text]
  • An Overview of COVID Vaccine Clinical Trial Results & Some Challenges
    An overview of COVID vaccine clinical trial results & some challenges DCVMN Webinar December 8th, 2020 Access to COVID-19 tools ACCESSACCESS TO TOCOVID-19 COVID-19 TOOLS TOOLS (ACT) (ACT) ACCELERATOR ACCELERATOR (ACT) accelerator A GlobalA GlobalCollaboration Collaboration to Accelerate tothe AccelerateDevelopment, the Production Development, and Equitable Production Access to New and Equitable AccessCOVID-19 to New diagnostics, COVID-19 therapeutics diagnostics, and vaccines therapeutics and vaccines VACCINES DIAGNOSTICS THERAPEUTICS (COVAX) Development & Manufacturing Led by CEPI, with industry Procurement and delivery at scale Led by Gavi Policy and allocation Led by WHO Key players SOURCE: (ACT) ACCELERATOR Commitment and Call to Action 24th April 2020 ACT-A / COVAX governance COVAX COORDINATION MEETING CEPI Board Co-Chair: Jane Halton Co-Chair: Dr. Ngozi Gavi Board Workstream leads + DCVMN and IFPMA-selected Reps As needed – R&D&M Chair; COVAX IPG Chair Development & Manufacturing Procurement and delivery Policy and allocation (COVAX) at scale Led by (with industry) Led by Led by R&D&M Investment Committee COVAX Independent Product Group Technical Review Group Portfolio Group Vaccine Teams SWAT teams RAG 3 COVAX SWAT teams are being set up as a joint platform to accelerate COVID- 19 Vaccine development and manufacturing by addressing common challenges together Timely and targeted Multilateral Knowledge-based Resource-efficient Addresses specific cross- Establishes a dialogue Identifies and collates Coordinates between developer technical and global joint effort most relevant materials different organizations/ challenges as they are across different COVID-19 and insights across the initiatives to limit raised and/or identified vaccines organizations broader COVID-19 duplications and ensure on an ongoing basis (incl.
    [Show full text]
  • Update 50 (15Th of December 2020)
    Update 50 (15th of December 2020) Information about Infection disease COVID-19 (novel coronavirus) Force Health Protection Branch FHPB (former DHSC) NATO MILMED COE in Munich 15th of December 2020 email: [email protected] In December 2019, a novel coronavirus emerged in Wuhan City, China. Since then the virus spread to 65 countries including Europe and America. Since then the virus showed evidence for human-to-human transmission as well as evidence of asymptomatic transmission. At 30th January 2020 WHO declared a Public Health Emergency of International Concern. The disease was formally named COVID-19 on 11th of February. The virus itself has been named SARS-CoV-2. On 11th of March 2020 WHO characterized the disease as a pandemic. HIGHLIGHTS/NEWS GLOBALLY ↗ • GBR/WHO: A new variant of the virus could be responsible for the renewed high number of cases in the UK, among other things, which 72 879 777 confirmed cases could be "in connection with the faster spread in the south of England". 47 710 950 recovered So far, 1000 cases have been identified. 1 622 200 deaths The WHO emphasized that the new variant would now be examined. EU/EEA and the UK ↘ However, there is no evidence that the strain behaves differently than 21 936 276 existing virus types. "We saw many variants, this virus evolves and confirmed cases changes over time." 10 689 950 recovered • Sputnik V: The developers of the Russian coronavirus vaccine Sputnik 479 566 deaths V explain that it creates 91.4 percent protection against the lung disease USA ↗ Covid-19.
    [Show full text]